JGB1741 CAS No.1256375-38-8
JGB1741 CAS No.1256375-38-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1427 | 10mg | 370.00 | + Add to cart |
|
| R-R-1427 | 25mg | 720.00 | + Add to cart |
|
|
|
||||
Product description
JGB1741 (ILS-JGB-1741)/CAS No.1256375-38-8 is a potent and specific SIRT1 activity inhibitor with an IC50 of ∼15 μM. JGB1741 is a weak SIRT2 and SIRT3 inhibitor with an all IC50>100 μM. JGB1741 increases the acetylated p53 levels leading to p53-mediated apoptosis with modulation of Bax/Bcl2 ratio, cytochrome c release and PARP cleavage. JGB1741 has the potential for breast cancer research.
| Appearance | N/A |
|---|---|
| Molecular Weight | 440.56 |
| Purity | >90% |
| CAS | 1256375-38-8 |
| Formula | C27H24N2O2S |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of JGB1741 CAS No.1256375-38-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


